Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$8.44 - $18.35 $393,920 - $856,449
-46,673 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$16.41 - $24.71 $111,374 - $167,706
6,787 Added 17.02%
46,673 $766,000
Q1 2021

May 19, 2021

BUY
$20.38 - $34.07 $119,549 - $199,854
5,866 Added 17.24%
39,886 $881,000
Q4 2020

Mar 08, 2021

BUY
$19.0 - $32.63 $646,380 - $1.11 Million
34,020 New
34,020 $1.05 Million

About TCR2 THERAPEUTICS INC.


  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.